Hikma Pharmaceutical | HIK - Capital Ordinaire

Prix De L'Action
1,465.00
Variation Quotidienne
-2.00 -0.14%
Mensuellement
4.46%
Annuel
-29.43%
Q2 Prévisions
1,414.37




Capital Ordinaire Changement Date
Almirall EUR 214.79M 0 2025-12
AstraZeneca USD 1.55B 73K 2026-03
Autolus Therapeutics Ltd USD 266.14M 0 2025-12
Bayer EUR 982.42M 0 2025-12
Fresenius EUR 563.24M 0 2025-12
Genmab DKK 61.62M 52K 2025-12
GlaxoSmithKline GBP 4.05B 20.6M 2026-03
GRIFOLS EUR 680.58M 0 2026-03
Hikma Pharmaceutical USD 221.89M 181.89M 2025-12
Lakefront Biotherapeutics EUR 65.9M 0 2026-03
Lonza CHF 68.64M 0 2025-12
Merck EUR 434.78M 0 2026-03
Orion EUR 140.87M 173K 2026-03
Recordati EUR 203.43M 928K 2026-03
Roche Holding CHF 795.62M 699.54K 2025-12
Sanofi EUR 1.21B 8.25M 2026-03
UCB EUR 190.36M 365.15K 2025-12